BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Genomic Grade Index (GGI): Feasibility in routine practice and impact on treatment decisions in early breast cancer

Dataset: Genomic Grade Index (GGI): Feasibility in routine practice and impact on treatment decisions in early breast cancer

Genomic Grade Index (GGI) is a 97-gene signature that improves histologic grade (HG) classification in invasive breast carcinoma. In this...

Registered by ArrayExpress Uploader
View Dataset

Genomic Grade Index (GGI) is a 97-gene signature that improves histologic grade (HG) classification in invasive breast carcinoma. In this prospective study we sought to evaluate the feasibility of performing GGI in routine clinical practice and its impact on treatment recommendations. Patients with pT1pT2 or operable pT3, N0-3 invasive breast carcinoma were recruited from 8 centers in Belgium. Fresh surgical samples were sent at room temperature in the MapQuant Dx™ PathKit for centralized genomic analysis. Genomic profiles were determined using Affymetrix U133 Plus 2.0 and GGI calculated using the MapQuant Dx™ protocol, which defines tumors as low or high Genomic Grade (GG-1 and GG-3 respectively). 180 pts were recruited and 155 were eligible. The MapQuant test was performed in 142 cases and GGI was obtained in 78% of cases (n=111). Reasons for failures were 15 samples with <30% of invasive tumor cells (11%), 15 with insufficient RNA quality (10%), and 1 failed hybridization (<1%). For tumors with an available representative sample (≥ 30% inv. tumor cells) (n=127), the success rate was 87.5 %. GGI reclassified 69% of the 54 HG2 tumors as GG-1 (54%) or GG-3 (46%). Changes in treatment recommendations occurred mainly in the subset of HG2 tumors reclassified into GG-3, with increased use of chemotherapy in this subset. The use of GGI is feasible in routine clinical practice and impacts treatment decisions in early-stage breast cancer. Total RNA was extracted from fresh tumor tissues comprising ≥30% invasive tumor cells and hybridized on Affymetrix microarrays if the RIN was ≥ 7.

Species:
human

Samples:
111

Source:
E-GEOD-43365

Updated:
Dec.12, 2014

Registered:
Jul.12, 2014


Factors: (via ArrayExpress)
Sample PR HIST CENTRE COMORB GRADE HISTO AGE GG MENOP SIZE MM HER2 NODES GGI ER
GSM1061142 1 lobular 1 average for age 2 80 equivocal postmenopausal 15 0 0 -0.3 1
GSM106114 1 ductal 1 minor 1 75 equivocal postmenopausal 10 0 0 0.2 1
GSM1061140 0 ductal 1 minor 3 42 3 premenopausal 17 0 0 2 1
GSM1061139 1 ductal 1 minor 1 51 1 postmenopausal 11 0 0 -1.5 1
GSM1061138 1 ductal 1 minor 3 41 3 NA 16 1 0 0.6 1
GSM1061137 0 ductal 6 perfect health 3 48 3 premenopausal 28 0 0 3.1 1
GSM1061136 1 ductal 6 perfect health 3 60 3 postmenopausal 8 1 0 0.5 1
GSM1061135 0 ductal 6 perfect health 1 56 1 NA 12 0 0 -0.6 1
GSM1061134 0 ductal 6 major problems 2 78 3 postmenopausal 45 0 1 0.4 1
GSM1061133 1 ductal 6 perfect health 2 43 1 premenopausal 12 0 0 -0.7 1
GSM1061132 1 ductal 6 perfect health 2 69 3 NA 42 0 2 1.4 1
GSM106113 0 ductal 6 perfect health 2 53 1 NA 18 0 0 -0.6 1
GSM1061130 1 lobular 6 perfect health 3 54 1 postmenopausal 32 1 0 -0.7 1
GSM1061129 1 ductal 6 major problems 2 63 1 NA 35 0 0 -1.1 1
GSM1061128 0 ductal 6 perfect health 3 38 3 premenopausal 17 0 0 2.4 0
GSM1061127 1 ductal 6 major problems 3 70 3 postmenopausal 45 0 1 1.6 1
GSM1061126 1 lobular 3 minor 2 53 1 postmenopausal 8 0 0 -1.2 1
GSM1061125 1 ductal 3 minor 2 62 equivocal postmenopausal 15 0 0 -0.3 1
GSM1061124 1 ductal 3 minor 2 58 equivocal postmenopausal 18 0 1 0.1 1
GSM1061123 1 ductal 3 minor 1 51 1 postmenopausal 12 0 0 -1 1
GSM1061122 1 ductal 1 minor 2 43 equivocal premenopausal 13 0 0 -0.1 1
GSM106112 1 lobular 6 minor 1 56 1 postmenopausal 20 0 0 -1 1
GSM1061120 0 ductal 6 perfect health 3 45 3 premenopausal 13 0 1 1.2 1
GSM1061119 1 ductal 6 major problems 2 64 1 postmenopausal 6 0 0 -1.9 1
GSM1061118 0 ductal 6 major problems 3 87 3 postmenopausal 45 1 0 1.9 0
GSM1061117 1 ductal 6 minor 2 51 1 NA 13 0 1 -0.4 1
GSM1061116 1 lobular 6 minor 2 67 1 postmenopausal 30 0 0 -2.3 1
GSM1061115 1 ductal 6 average for age 1 84 1 postmenopausal 13 0 0 -0.8 1
GSM1061114 0 ductal 9 perfect health 2 56 3 postmenopausal 9 0 0 0.8 0
GSM1061113 0 ductal 9 perfect health 3 47 3 premenopausal 33 0 0 3.3 0
GSM1061112 1 ductal 9 perfect health 1 78 1 postmenopausal 17 0 0 -0.5 1
GSM106 0 ductal 6 NA 3 76 3 postmenopausal 30 1 2 1.6 0
GSM1061110 1 ductal 6 major problems 2 53 equivocal NA 15 0 0 -0.1 1
GSM1061109 1 lobular 6 major problems 1 52 1 premenopausal 12 0 0 -2.3 1
GSM1061108 1 ductal 6 minor 2 47 1 NA 16 0 0 -1.5 1
GSM1061107 1 ductal 6 major problems 1 49 3 premenopausal 15 0 0 1 1
GSM1061106 1 ductal 6 perfect health 2 58 3 NA 15 NA 0 0.7 1
GSM1061105 1 ductal 6 minor 3 77 3 postmenopausal 22 0 3 1.3 1
GSM1061104 0 ductal 6 minor 2 60 equivocal postmenopausal 9 0 0 0.1 1
GSM1061103 0 ductal 6 average for age 2 75 3 postmenopausal 25 0 2 0.9 1
GSM1061102 1 ductal 6 minor 3 63 3 NA 18 1 1 0.8 1
GSM106110 1 ductal 6 perfect health 2 66 1 postmenopausal 15 0 0 -0.6 1
GSM1061100 0 ductal 6 perfect health 3 49 3 premenopausal 15 1 2 0.8 0
GSM1061099 1 ductal 9 perfect health 2 47 3 premenopausal 20 0 0 0.4 1
GSM1061098 1 ductal 9 perfect health 2 55 3 postmenopausal 17 0 0 2 1
GSM1061097 0 ductal 9 perfect health 2 44 3 premenopausal 26 0 0 0.7 1
GSM1061096 1 ductal 9 perfect health 2 64 1 postmenopausal 13 0 0 -1 1
GSM1061095 0 ductal 9 perfect health 2 64 3 postmenopausal 32 0 1 0.4 1
GSM1061094 1 ductal 9 perfect health 1 49 1 premenopausal 21 0 0 -0.6 1
GSM1061093 1 ductal 9 perfect health 2 44 1 premenopausal 15 0 0 -0.6 1
GSM1061092 1 ductal 9 perfect health 2 44 3 premenopausal 25 0 0 1.1 1
GSM106109 1 lobular 9 perfect health 2 42 1 premenopausal 17 0 0 -1.2 1
GSM1061090 0 ductal 9 perfect health 3 31 3 premenopausal 23 0 0 2.8 0
GSM1061089 1 ductal 9 perfect health 2 53 equivocal premenopausal 19 0 0 -0.1 1
GSM1061088 0 lobular 9 average for age 3 82 1 postmenopausal 27 0 0 -0.3 0
GSM1061087 1 ductal 9 perfect health 1 64 1 postmenopausal 12 0 0 -0.8 1
GSM1061086 1 ductal 9 perfect health 2 61 1 postmenopausal 15 0 0 -0.4 1
GSM1061085 0 lobular 9 perfect health 3 73 3 postmenopausal 22 0 0 0.4 1
GSM1061084 0 ductal 9 average for age 3 82 3 postmenopausal 22 1 0 0.4 0
GSM1061083 1 ductal 9 perfect health 2 65 1 postmenopausal 11 0 1 -2.2 1
GSM1061082 0 ductal 9 perfect health 3 35 3 premenopausal 22 0 1 2.9 1
GSM106108 1 ductal 2 perfect health 2 61 equivocal postmenopausal 25 0 1 -0.1 1
GSM1061080 1 ductal 2 minor 1 48 1 premenopausal 10 0 0 -2.5 1
GSM1061079 1 ductal 2 minor 2 58 equivocal postmenopausal 30 0 1 0.2 1
GSM1061078 1 ductal 2 minor 2 47 equivocal premenopausal 17 0 0 -0.1 1
GSM1061077 1 ductal 1 minor 3 71 equivocal postmenopausal 42 0 0 0.1 1
GSM1061076 0 ductal 1 average for age 2 71 equivocal postmenopausal 12 0 0 -0.1 0
GSM1061075 1 ductal 1 average for age 3 78 3 postmenopausal 42 1 0 0.6 1
GSM1061074 1 ductal 1 minor 2 49 equivocal premenopausal 15 0 0 -0.2 1
GSM1061073 1 ductal 1 average for age 3 55 3 postmenopausal 12 0 0 1.3 1
GSM1061072 1 ductal 1 average for age 3 73 3 postmenopausal 40 0 3 1.5 1
GSM106107 1 ductal 1 perfect health 1 42 1 premenopausal 41 0 0 -0.8 1
GSM1061070 1 ductal 1 major problems 1 81 equivocal postmenopausal 14 0 0 -0.2 1
GSM1061069 1 ductal 6 minor 3 42 equivocal premenopausal 17 0 0 0.2 1
GSM1061068 1 lobular 6 average for age 1 78 equivocal postmenopausal 19 0 0 -0.3 1
GSM1061067 1 ductal 6 perfect health 3 53 3 premenopausal 21 0 1 0.4 1
GSM1061066 0 ductal 9 perfect health 2 50 1 postmenopausal 15 1 0 -0.3 1
GSM1061065 0 ductal 9 perfect health 2 39 3 premenopausal 13 0 0 2.4 0
GSM1061064 1 lobular 9 perfect health 2 53 equivocal postmenopausal 28 0 3 -0.2 1
GSM1061063 1 ductal 9 perfect health 3 41 3 premenopausal 28 0 1 1.5 1
GSM1061062 0 ductal 9 perfect health 3 46 3 premenopausal 32 0 0 3.1 0
GSM106106 0 ductal 3 minor 1 66 1 postmenopausal 9 0 0 -2 1
GSM1061060 0 ductal 3 major problems 3 69 3 postmenopausal 21 0 0 3.1 0
GSM1061059 1 ductal 3 major problems 2 60 3 postmenopausal 24 0 0 0.6 1
GSM1061058 1 lobular 3 minor 3 54 3 postmenopausal 35 0 0 0.9 1
GSM1061057 1 ductal 3 NA 3 71 3 postmenopausal 19 0 0 1.5 1
GSM1061056 1 ductal 3 average for age 1 76 equivocal postmenopausal 24 0 0 -0.2 1
GSM1061055 1 ductal 3 perfect health 1 78 equivocal postmenopausal 18 0 0 -0.3 1
GSM1061054 1 ductal 8 perfect health 3 73 1 postmenopausal 44 0 3 -0.6 1
GSM1061053 0 ductal 2 minor 3 48 3 premenopausal 11 0 0 1.2 0
GSM1061052 1 ductal 2 minor 2 56 equivocal postmenopausal 16 1 2 0.3 1
GSM106105 1 ductal 2 minor 2 77 1 postmenopausal 11 0 1 -1 1
GSM1061050 1 ductal 2 minor 2 51 1 premenopausal 28 0 1 -1.5 1
GSM1061049 1 ductal 2 minor 1 67 1 postmenopausal 18 0 0 -2.3 1
GSM1061048 1 ductal 2 perfect health 2 48 equivocal premenopausal 10 0 0 0 1
GSM1061047 1 ductal 6 perfect health 3 67 1 postmenopausal 18 0 1 -0.4 1
GSM1061046 0 ductal 6 perfect health 2 66 3 postmenopausal 50 0 0 0.7 1
GSM1061045 1 ductal 6 minor 1 72 1 postmenopausal 11 0 3 -1.8 1
GSM1061044 1 ductal 6 perfect health 2 53 1 NA 12 0 0 -1.3 1
GSM1061043 0 ductal 6 minor 3 54 3 postmenopausal 45 1 0 1.5 0
GSM1061042 0 ductal 6 perfect health 2 61 3 postmenopausal 10 0 0 0.6 1
GSM106104 1 lobular 1 major problems 2 81 equivocal postmenopausal 15 0 0 0.1 1
GSM1061040 1 ductal 1 minor 2 47 equivocal premenopausal 13 0 0 0 1
GSM1061039 0 ductal 1 NA 3 90 3 postmenopausal 18 NA 0 0.4 0
GSM1061038 1 lobular 1 minor 2 61 1 postmenopausal 11 0 0 -0.8 1
GSM1061037 1 lobular 1 average for age 1 76 1 postmenopausal 16 0 0 -2.2 1
GSM1061036 0 ductal 1 perfect health 3 43 3 NA 19 0 0 2.5 0
GSM1061035 1 ductal 1 average for age 2 65 1 postmenopausal 30 0 0 -0.6 1
GSM1061034 0 ductal 4 average for age 2 59 3 postmenopausal 10 1 0 0.5 0
GSM1061033 1 ductal 4 major problems 2 60 3 postmenopausal 22 0 0 2.2 1
GSM1061032 1 ductal 6 perfect health 2 68 3 postmenopausal 17 0 0 0.7 1

Tags

  • breast
  • breast cancer
  • breast carcinoma
  • cancer
  • carcinoma

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use